EDGAR Filing Documents for 0001262463-13-000736

Form 8-K - Current report:

SEC Accession No. 0001262463-13-000736

Filing Date

2013-11-12

Accepted

2013-11-12 10:16:16

Documents

Period of Report

2013-11-11

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	plpl111113.htm	8-K	10453
	Complete submission text file	0001262463-13-000736.txt		11718

Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102

Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (435) 881-8734

Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51206 | Film No.: 131207710
SIC: 2834 Pharmaceutical Preparations